IL138339A0 - Mutant recombinant allergens - Google Patents

Mutant recombinant allergens

Info

Publication number
IL138339A0
IL138339A0 IL13833999A IL13833999A IL138339A0 IL 138339 A0 IL138339 A0 IL 138339A0 IL 13833999 A IL13833999 A IL 13833999A IL 13833999 A IL13833999 A IL 13833999A IL 138339 A0 IL138339 A0 IL 138339A0
Authority
IL
Israel
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
IL13833999A
Other languages
English (en)
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL138339(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of IL138339A0 publication Critical patent/IL138339A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
IL13833999A 1998-03-16 1999-03-16 Mutant recombinant allergens IL138339A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16
PCT/DK1999/000136 WO1999047680A1 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens

Publications (1)

Publication Number Publication Date
IL138339A0 true IL138339A0 (en) 2001-10-31

Family

ID=8092687

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13833999A IL138339A0 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens
IL138339A IL138339A (en) 1998-03-16 2000-09-07 Non naturally occurring mutant recombinant allergens, methods for their preparation and pharmaceutical compositions comprising them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL138339A IL138339A (en) 1998-03-16 2000-09-07 Non naturally occurring mutant recombinant allergens, methods for their preparation and pharmaceutical compositions comprising them

Country Status (20)

Country Link
US (1) US20040091500A1 (pl)
EP (1) EP1062341B1 (pl)
JP (1) JP2002506648A (pl)
KR (1) KR20010041918A (pl)
CN (1) CN1332029C (pl)
AT (1) ATE408690T1 (pl)
AU (1) AU749749B2 (pl)
CA (1) CA2323687C (pl)
DE (1) DE69939584D1 (pl)
DK (1) DK1062341T3 (pl)
ES (1) ES2313776T3 (pl)
HK (1) HK1033591A1 (pl)
HU (1) HUP0101464A3 (pl)
IL (2) IL138339A0 (pl)
NO (1) NO328354B1 (pl)
NZ (1) NZ506665A (pl)
PL (1) PL194804B1 (pl)
PT (1) PT1062341E (pl)
WO (1) WO1999047680A1 (pl)
ZA (1) ZA200004819B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192792A1 (en) * 2000-04-28 2002-12-19 Palle Schneider Laccase mutants
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
EP1340085B1 (en) * 2000-10-17 2008-07-30 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
MXPA03004174A (es) * 2000-11-16 2004-12-02 Alk Abello As Alergenos mutantes novedosos.
EP1219300B1 (en) * 2000-12-28 2006-12-06 BIOMAY Produktions- und Handels- Aktiengesellschaft Treatment of allergies
CA2441476A1 (en) * 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
CA2462651A1 (en) * 2001-10-05 2003-04-17 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
CN1668737A (zh) * 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
CA2503886A1 (en) * 2002-11-01 2004-05-13 Alk-Abello A/S Recombinant protein variants
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
WO2004075875A1 (en) 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
BRPI0417264A (pt) 2003-12-19 2007-03-06 Alk Abello As processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno
CA2624503A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
ITMI20052517A1 (it) 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
JP2009534029A (ja) * 2006-04-20 2009-09-24 ナショナル ユニバーシティ オブ シンガポール 組換え乳酸桿菌およびその使用
ES2527412T3 (es) * 2007-02-15 2015-01-23 Mannkind Corporation Método para aumentar la respuesta de los linfocitos T
EP1974746B1 (en) 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010146171A1 (en) 2009-06-19 2010-12-23 Alk-Abelló A/S Novel manner of administering allergen in allergen specific immunotherapy
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
IL138339A (en) 2009-06-15
HUP0101464A2 (hu) 2001-08-28
PL343029A1 (en) 2001-07-30
NO328354B1 (no) 2010-02-01
DE69939584D1 (de) 2008-10-30
AU2714799A (en) 1999-10-11
HUP0101464A3 (en) 2004-10-28
NO20004614L (no) 2000-10-26
CN1332029C (zh) 2007-08-15
WO1999047680A1 (en) 1999-09-23
ES2313776T3 (es) 2009-03-01
CA2323687A1 (en) 1999-09-23
KR20010041918A (ko) 2001-05-25
US20040091500A1 (en) 2004-05-13
CA2323687C (en) 2008-11-25
AU749749B2 (en) 2002-07-04
PL194804B1 (pl) 2007-07-31
EP1062341B1 (en) 2008-09-17
HK1033591A1 (en) 2001-09-07
JP2002506648A (ja) 2002-03-05
CN1293710A (zh) 2001-05-02
DK1062341T3 (da) 2008-11-03
NO20004614D0 (no) 2000-09-15
NZ506665A (en) 2003-08-29
EP1062341A1 (en) 2000-12-27
ATE408690T1 (de) 2008-10-15
ZA200004819B (en) 2001-05-30
PT1062341E (pt) 2008-12-24

Similar Documents

Publication Publication Date Title
IL138339A0 (en) Mutant recombinant allergens
AU2350502A (en) Novel mutant allergens
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
WO2003020889A3 (en) Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
AU3227700A (en) Skin sanitizing compositions
BG102818A (en) D-manitol and method for its preparation
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
MX9708426A (es) Polipeptido hk2 de variante estable.
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
BG101787A (en) Aprotinine options having improved properties
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
IL153576A0 (en) Dna vaccines encoding hiv accessory proteins
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
EP1689430A4 (en) TYROSINE MUTANT AND METHOD OF USE THEREOF
WO1999015160A3 (en) Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
WO2001048205A3 (en) Murine neu sequences and methods of use therefor
DE69225039D1 (de) Mikroorganismen und Verfahren zur Herstellung von 3-Alpha, 7-Alpha-Dihydroxy-12-Keto-Cholansäure